๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Evidence for high-risk haplotypes and (CGG)n expansion in fragile X syndrome in the Hellenic population of Greece and Cyprus

โœ Scribed by Syrrou, Maria; Patsalis, Philippos C.; Georgiou, Ioannis; Hadjimarcou, Michael I.; Constantinou-Deltas, C. D.; Pagoulatos, Gerassimos


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
32 KB
Volume
64
Category
Article
ISSN
0148-7299

No coin nor oath required. For personal study only.

โœฆ Synopsis


The expansion of the trinucleotide repeat (CGG)n in successive generations through maternal meiosis is the cause of fragile X syndrome. Analysis of CA repeat polymorphisms flanking the FMR-1 gene provides evidence of a limited number of "founder" chromosomes and predisposing high-risk haplotypes related to the mutation. To investigate the origin of mutations in the fragile X syndrome in the Hellenic populations of Greece and Cyprus, we studied the alleles and haplotypes at DXS548 and FRAXACS loci of 16 independent fragile X and 70 normal control chromosomes. In addition, we studied 191 unrelated normal X chromosomes for the distribution and frequencies of CGG alleles. At DXS548,6 alleles were found, 2 (194 and 196) of which were represented on fragile X chromosomes. At FRAXACS, 6 alleles were found, 4 of which were present on fragile X chromosomes. Sixteen haplotypes were identified, but only 5 were present on fragile X chromosomes. The highest number of CGG repeats (2 33) were associated with haplotypes 194-147, 194-151, 194-153, and 204-155. The data provide evidence for founder chromosomes and high-risk haplotypes in the Hellenic population.


๐Ÿ“œ SIMILAR VOLUMES


Molecular screening of fragile X (FRAXA)
โœ Patsalis, P.C.; Sismani, C.; Hettinger, J.A.; Boumba, I.; Georgiou, I.; Styliani ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 62 KB ๐Ÿ‘ 2 views

This study presents the first large, population-based molecular investigation of the fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic populations of Greece and Cyprus. The aims of this population screening were to determine the prevalence of FRAXA and FRAXE syndromes among id